Pittman, Cory B <br/><br/>
Myocardial infarction risk among patients with fractures receiving bisphosphonates.  [electronic resource] 

 -  Mayo Clinic proceedings  Jan 2014 
 - 43-51 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1942-5546 
<br/><br/><label>Standard No.: </label>10.1016/j.mayocp.2013.08.021  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Age Factors<br/>Aged<br/>Aged, 80 and over<br/>Bone Density Conservation Agents--adverse effects<br/>Causality<br/>Cohort Studies<br/>Comorbidity<br/>Databases, Factual--statistics & numerical data<br/>Diphosphonates--adverse effects<br/>Female<br/>Femoral Fractures--drug therapy<br/>Humans<br/>Incidence<br/>Male<br/>Myocardial Infarction--chemically induced<br/>Osteoporosis--drug therapy<br/>Retrospective Studies<br/>Risk Factors<br/>Sex Factors<br/>Spinal Fractures--drug therapy<br/>Survival Analysis<br/>United States--epidemiology<br/>United States Department of Veterans Affairs--statistics & numerical data<br/>Veterans